Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways

<div>The characterization of cell surface markers expression in the isolated AD-MSCs was evaluated by flow cytometry. AD-MSCs were markedly positive for MSCs special biomarkers, including CD73, CD105, and CD90. While being negative for the hematopoietic biomarkers CD45 and CD34.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways 

Figure 2 | Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways 